Abstract
The principle of this method was to screen the pharmacological activity of ten prepared polyphyto formulations by using highthroughput screening method for their antihyperlipidemic activity. The study was performed in three stages using single animal, two animals and three animals in a group. The data produced with single animal is compared with the average data shown by two and three experimental animals and further with six animals (one way ANOVA) for the statistical significance and was duly reported. R2 value was determined by Least squares linear regression analysis to interpret as the proportion of the variance in the dependent variable that is predictable from the independent variable. Test formulations were given at 50mg/kg, body weight through p.o. route daily for 14 days in experimental animals induced with hyperlipidemia by injecting Triton X-100 at 100 mg/kg BW i/p and observed for 48 hrs for the development of hyperlipidemia. Two best formulations namely PHF-21 and PHF-26 were selected by highthroughput screening and results repeated in six animals in a group were found to be statically similar.
Keywords: Antihyperlipidemic, ANOVA, highthroughput, linear regression, Triton X-100.
Graphical Abstract
Current Bioactive Compounds
Title:Preliminary Pharmacological Screening of Anti-Hyperlipidemic Polyphyto Combination by Novelistic Highthroughput Screening Method
Volume: 12 Issue: 2
Author(s): Asha Bisht, Satheesh N.V. Madhav and Kumud Upadhyaya
Affiliation:
Keywords: Antihyperlipidemic, ANOVA, highthroughput, linear regression, Triton X-100.
Abstract: The principle of this method was to screen the pharmacological activity of ten prepared polyphyto formulations by using highthroughput screening method for their antihyperlipidemic activity. The study was performed in three stages using single animal, two animals and three animals in a group. The data produced with single animal is compared with the average data shown by two and three experimental animals and further with six animals (one way ANOVA) for the statistical significance and was duly reported. R2 value was determined by Least squares linear regression analysis to interpret as the proportion of the variance in the dependent variable that is predictable from the independent variable. Test formulations were given at 50mg/kg, body weight through p.o. route daily for 14 days in experimental animals induced with hyperlipidemia by injecting Triton X-100 at 100 mg/kg BW i/p and observed for 48 hrs for the development of hyperlipidemia. Two best formulations namely PHF-21 and PHF-26 were selected by highthroughput screening and results repeated in six animals in a group were found to be statically similar.
Export Options
About this article
Cite this article as:
Bisht Asha, N.V. Madhav Satheesh and Upadhyaya Kumud, Preliminary Pharmacological Screening of Anti-Hyperlipidemic Polyphyto Combination by Novelistic Highthroughput Screening Method, Current Bioactive Compounds 2016; 12 (2) . https://dx.doi.org/10.2174/157340721202160504221515
DOI https://dx.doi.org/10.2174/157340721202160504221515 |
Print ISSN 1573-4072 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6646 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Roles of p75NTR in Maintaining Brain Hemostasis and the Implications for p75NTR-targeted Therapies
Current Alzheimer Research Robotic Assisted Surgery in Gynecology: Current Insights and Future Perspectives
Recent Patents on Biotechnology Molecular Effects of the CTG Repeats in Mutant Dystrophia Myotonica Protein Kinase Gene
Current Genomics The Endocannabinoid System: A New Molecular Target for the Treatment of Tobacco Addiction
CNS & Neurological Disorders - Drug Targets Third and Fourth Generation Fluoroquinolone Antibacterials: A Systematic Review of Safety and Toxicity Profiles
Current Drug Safety New Molecular Avenues in Parkinson ’ s Disease Therapy
Current Topics in Medicinal Chemistry Anti-Parkinsonian Effects of Nurr1 Activator in Ubiquitin-Proteasome System Impairment Induced Animal Model of Parkinson’s Disease
CNS & Neurological Disorders - Drug Targets Structure-Based Design, Synthesis and Molecular Modeling Studies of Thiazolyl Urea Derivatives as Novel Anti-Parkinsonian Agents
Medicinal Chemistry Bis(thiosemicarbazone) Metal Complexes as Therapeutics for Neurodegenerative Diseases
Current Topics in Medicinal Chemistry Non-invasive Cerebellar Stimulation in Cerebellar Disorders
CNS & Neurological Disorders - Drug Targets Phosphodiesterase as a New Therapeutic Target for the Treatment of Spinal Cord Injury and Neurodegenerative Diseases
Current Medicinal Chemistry Concepts for Biologically Active Peptides
Current Pharmaceutical Design Recent Advances in the Molecular Pathogenesis of Dystonia-Plus Syndromes and Heredodegenerative Dystonias
Current Neuropharmacology Tauopathies – Focus on Changes at the Neurovascular Unit
Current Alzheimer Research Patent Annotations
Recent Patents on CNS Drug Discovery (Discontinued) The Association of Very High Hair Manganese Accumulation and High Oxidative Stress in Mongolian People
Current Aging Science mTOR, a Potential Target to Treat Autism Spectrum Disorder
CNS & Neurological Disorders - Drug Targets Copper Status Abnormalities and How to Measure Them in Neurodegenerative Disorders
Recent Patents on CNS Drug Discovery (Discontinued) A High Accumulation of Hair Minerals in Mongolian People: 2nd Report; Influence of Manganese, Iron, Lead, Cadmium and Aluminum to Oxidative Stress, Parkinsonism and Arthritis
Current Aging Science Current Trends on Antipsychotics: Focus on Asenapine
Current Medicinal Chemistry